Submission Details
| 510(k) Number | K191785 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 03, 2019 |
| Decision Date | February 14, 2020 |
| Days to Decision | 226 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K191785 is an FDA 510(k) clearance for the Orion LifeSpan MEG, a Magnetoencephalograph (Class II — Special Controls, product code OLY), submitted by Compumedics Limited (Abbotsford, AU). The FDA issued a Cleared decision on February 14, 2020, 226 days after receiving the submission on July 3, 2019. This device falls under the Neurology review panel. Regulated under 21 CFR 882.1400.
| 510(k) Number | K191785 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 03, 2019 |
| Decision Date | February 14, 2020 |
| Days to Decision | 226 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | OLY — Magnetoencephalograph |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.1400 |
| Definition | Acquire, Display, Store, And Archive Biomagnetic Signals Produced By Electrically Active Nerve Tissue In The Brain To Provide Information About The Location Of Active Nerve Tissue Responsible For Certain Brain Functions Relative To Brain Anatomy. |